Christopher McCarthy
Equibles does not estimate personal net worth.
About Christopher McCarthy
Christopher McCarthy is recorded as CFO at Interpace Biosciences, Inc. (IDXG). The newest filing on record that lists Christopher McCarthy as CFO at Interpace Biosciences, Inc. (IDXG) is dated July 7, 2026. Interpace Biosciences, Inc. reported in an 8-K filed August 2, 2023 that Christopher McCarthy was appointed Chief Financial Officer, effective July 24, 2023. Interpace Biosciences, Inc. reported in an 8-K filed April 25, 2023 that Christopher McCarthy was appointed Principal Financial Officer, effective April 21, 2023. Interpace Biosciences, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Interpace Biosciences, Inc. includes Thomas Burnell (CEO), Thomas W. Burnell (CEO and Board Member), Thomas J. Freeburg (CFO) and 7 others.
“On July 24, 2023, the Board of Directors (the “Board”) of Interpace Biosciences, Inc. (the “Company”) appointed Christopher McCarthy, age 32, as Chief Financial Officer.”
“On April 21, 2023, the Board of Directors of Interpace Biosciences, Inc. (the "Company") appointed Christopher McCarthy, age 31, who has served as the Company's Vice President of Finance and Enterprise Systems since August 2022, as Principal Financial Officer.”
Affiliation history
-
Current
Start not stated–present
Last confirmed July 7, 2026
Company network
Leadership on record at Interpace Biosciences, Inc.
- Thomas Burnell CEO
- Thomas W. Burnell CEO, Board Member
- Thomas J. Freeburg CFO
- Dr. Vijay Aggarwal Board Member
- Eric Lev Board Member
- Fortunato Ron Rocca Board Member
- Jack E. Stover Board Member
- Joseph Keegan, PhD Board Member
- Ron Rocca Board Member
- Stephen J. Sullivan Board Member